Goldan Keith A. sold SNDX
June 1, 2026 · Form 4 insider transaction
Goldan Keith A. sold 1,177 shares of Syndax Pharmaceuticals, Inc. at $18.99 per share, a transaction worth $22.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,177
Price
$18.99
Total value
$22.4K
InsiderGoldan Keith A.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after139,252
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.